Company intelligence / Profile preview

Coriell Life Sciences

Philadelphia, Pennsylvania, United Statescoriell.com ↗

Ownership: Private
Employees: ~17
Development stage: Commercial

Overview

Coriell Life Sciences developed commercialized precision medicine solutions using pharmacogenomics to optimize medication regimens. Their programs have demonstrated improved patient outcomes by reducing adverse drug reactions and healthcare costs through personalized genetic insights for prescribing. The company was acquired by InformedDNA in March 2025.

Therapeutic areas: OtherInfectious Diseases
Modalities: Genetic testingClinical decision support software
Industry: Molecular Diagnostics

Partnerships

Partnered with large employersHealth plans/payersPublic sector organizationsLaboratories

Beyond the preview

Go deeper on Coriell Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coriell Life Sciences.

Explore the full profile